Stevanato Group S.p.A.
About Stevanato Group S.p.A.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Market cap
- $5.0B
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $5.0B
- Dividend yield
- 0.3%
- Shares outstanding
- 280.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 16, 2021
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Trading 36% below its 52-week high.
- Pays a dividend yielding about 0.3% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Stevanato Group S.p.A..
Write a review
News about Stevanato Group S.p.A.
News & sentiment via Polygon.io
